Biotech · Private company
Oryn Therapeutics, LLC
Track this companyFree. Adds Oryn Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- ORTD-1 high dosePhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- ORTD-1 low dosePhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- ORTD-1 mid dosePhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle controlPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- High dose ORTD-1Phase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- High dose vehicle controlPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Low dose ORTD-1Phase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Low dose vehicle controlPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related PneumoniaPHASE1_PHASE2 · WITHDRAWN · started Apr 1, 2021ClinicalTrials.gov NCT04708236 · fetched Nov 12, 2026
- Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDsPHASE1 · COMPLETED · started Mar 22, 2021ClinicalTrials.gov NCT04286789 · fetched Nov 12, 2026